Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 40551-40600 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05786625
Bronchoscopic Microwave Ablation of Lung Tissue
N/ARecruiting
32 participants
Started: May 4, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT05858814
RC1012 Injection (Allo-DNT Cells) for the Prevention of Relapse in AML Patients After Allo-HSCT
PHASE1/PHASE2Recruiting
72 participants
Started: May 4, 2023 · Completed: Jun 24, 2026
1 condition2 sponsors1 location
NCT06133647
Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
N/ARecruiting
8 participants
Started: May 4, 2023 · Completed: May 4, 2024
2 conditions1 sponsor2 locations
NCT05339451
Blood and Tissue Markers for Improving Diagnosis and Prognosis of Endometriosis. (ENDOBIO)
N/ARecruiting
345 participants
Started: May 4, 2023 · Completed: Dec 31, 2026
1 condition4 sponsors3 locations
NCT05795101
TRUDI: TDXD+Durva in HER2+/Low IBC
PHASE2Recruiting
63 participants
Started: May 4, 2023 · Completed: Dec 1, 2032
5 conditions3 sponsors3 locations
NCT05844865
Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis
NARecruiting
20 participants
Started: May 4, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05823376
Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease
N/ARecruiting
40 participants
Started: May 4, 2023 · Completed: Feb 28, 2025
1 condition1 sponsor1 location
NCT04955795
Telemedicine for Unhealthy Alcohol Use in Persons Living With HIV Using CETA
NARecruiting
308 participants
Started: May 4, 2023 · Completed: Sep 30, 2027
2 conditions2 sponsors5 locations
NCT06269809
Temporary Artery Clipping for Robotically-assisted Myomectomy, a Multicentric Randomized Controlled Trial
NARecruiting
82 participants
Started: May 4, 2023 · Completed: May 30, 2025
1 condition4 sponsors4 locations
NCT05559749
Collaborative Care for Anxiety and Depression in Epilepsy
NARecruiting
60 participants
Started: May 4, 2023 · Completed: Aug 31, 2026
3 conditions1 sponsor1 location
NCT05840107
Study of FasT CAR-T GC012F Injection NDMM Patients
EARLY_PHASE1Recruiting
18 participants
Started: May 4, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05831878
RC48-ADC in HER2-low Advanced Breast Cancer
NARecruiting
36 participants
Started: May 4, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05324683
ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO)
N/ARecruiting
2,000 participants
Started: May 4, 2023 · Completed: Jan 30, 2026
1 condition2 sponsors1 location
NCT05866536
Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years
PHASE2Recruiting
100 participants
Started: May 4, 2023 · Completed: May 31, 2028
4 conditions1 sponsor1 location
NCT05726487
Physical Activity Intervention for Black Women With Asthma
NARecruiting
224 participants
Started: May 4, 2023 · Completed: Jun 3, 2026
1 condition3 sponsors2 locations
NCT06034288
Xeomin vs Botox for Treatment of Overactive Bladder Syndrome
PHASE2Recruiting
64 participants
Started: May 4, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT05894369
Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
N/ARecruiting
10 participants
Started: May 4, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05841186
Correlation of Timing of Pegfilgrastim Administration and PIBP.
NARecruiting
156 participants
Started: May 4, 2023 · Completed: May 31, 2025
6 conditions1 sponsor1 location
NCT06302738
Phenotypisation of Sleep Pattern in Hypertensive Patients With Non Dipper Pattern
N/ARecruiting
143 participants
Started: May 4, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor11 locations
NCT05541250
Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)
PHASE1Recruiting
30 participants
Started: May 4, 2023 · Completed: Sep 29, 2026
1 condition2 sponsors1 location
NCT05716516
STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)
PHASE2Recruiting
36 participants
Started: May 4, 2023 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT03608280
Efficiency of 3D-printed Implant Versus Autograft for Orbital Reconstruction (TOR-3D)
NARecruiting
92 participants
Started: May 4, 2023 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT06905119
Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters: SpadCare Experience
NARecruiting
201 participants
Started: May 4, 2023 · Completed: Jul 31, 2026
23 conditions2 sponsors1 location
NCT05894746
Gfree - For Improved Blood Sugar and Reduced Inflammation.
NARecruiting
60 participants
Started: May 4, 2023 · Completed: Dec 31, 2030
4 conditions4 sponsors2 locations
NCT05808504
Investigation of the Benefits of Electrical Non-invasive Stimulation on Cognitive Symptoms in Parkinson's Disease
NARecruiting
90 participants
Started: May 3, 2023 · Completed: Jan 15, 2026
1 condition1 sponsor1 location
NCT05639569
Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study
N/ARecruiting
145 participants
Started: May 3, 2023 · Completed: Dec 30, 2030
2 conditions1 sponsor8 locations
NCT05755854
Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors
PHASE1Recruiting
10 participants
Started: May 3, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06380140
Relationship Between Acute Phase Markers and Post-operative Pain in Open Tension-free Inguinal Hernia Repair: An Observational Study
N/ARecruiting
71 participants
Started: May 3, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05733715
Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma
EARLY_PHASE1Recruiting
30 participants
Started: May 3, 2023 · Completed: Jan 31, 2028
1 condition2 sponsors1 location
NCT06070974
ExosoMe as Integrative Tool for pRognostic Stratification of Adverse Cardiac remodeLing in stEmi Patients: the MIRACLE Study
N/ARecruiting
100 participants
Started: May 3, 2023 · Completed: Apr 30, 2026
1 condition2 sponsors2 locations
NCT05890092
Vulvar Disease in Nigeria Observational Study
N/ARecruiting
1,000 participants
Started: May 3, 2023 · Completed: Nov 30, 2026
3 conditions1 sponsor1 location
NCT05910476
Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)
PHASE4Recruiting
200 participants
Started: May 3, 2023 · Completed: Sep 22, 2026
2 conditions2 sponsors1 location
NCT05743673
SHAPE Test for Preoperative Risk Stratification
N/ARecruiting
200 participants
Started: May 3, 2023 · Completed: May 29, 2026
2 conditions1 sponsor1 location
NCT05876754
An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma
PHASE3Recruiting
220 participants
Started: May 3, 2023 · Completed: Jun 1, 2025
1 condition1 sponsor78 locations
NCT05794022
Cohort of STEMI Patients 2
NARecruiting
300 participants
Started: May 3, 2023 · Completed: Jun 3, 2031
1 condition1 sponsor2 locations
NCT06954636
Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study
N/ARecruiting
128 participants
Started: May 3, 2023 · Completed: Dec 31, 2028
3 conditions2 sponsors2 locations
NCT05918328
Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC
PHASE2Recruiting
610 participants
Started: May 3, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04883255
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
EARLY_PHASE1Recruiting
138 participants
Started: May 3, 2023 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT05782361
POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC
PHASE1Recruiting
19 participants
Started: May 3, 2023 · Completed: Jan 9, 2029
2 conditions3 sponsors4 locations
NCT05721209
Virtual Reality Treadmill Training in Individuals with Traumatic Brain Injury
NARecruiting
20 participants
Started: May 3, 2023 · Completed: Dec 23, 2025
1 condition1 sponsor1 location
NCT05592015
Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
PHASE2Recruiting
28 participants
Started: May 3, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT06851988
Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients
NARecruiting
180 participants
Started: May 3, 2023 · Completed: Oct 30, 2027
3 conditions1 sponsor1 location
NCT05880342
The Role of the Brain in Mental and Physical Fatigue
PHASE3Recruiting
62 participants
Started: May 3, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05483465
The Effect of NAD Supplementation on Brain Vascular Health in Aging
PHASE4Recruiting
214 participants
Started: May 3, 2023 · Completed: Dec 31, 2027
1 condition4 sponsors1 location
NCT06871657
Comparing Two Surgical Techniques for Building Up the Bone Where a Dental Implant is to Be Placed
N/ARecruiting
30 participants
Started: May 3, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT06745999
Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face
PHASE4Recruiting
40 participants
Started: May 3, 2023 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05831865
Frontline of ASCT in High-risk DLBCL
N/ARecruiting
175 participants
Started: May 3, 2023 · Completed: Apr 27, 2027
1 condition2 sponsors1 location
NCT05805202
Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy
NARecruiting
112 participants
Started: May 3, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06463808
Effect of Recombinant Human Brain Natriuretic Peptide on Ventricular Remodeling and Cardiac Function in Patients With Acute Anterior Myocardial Infraction Undergoing Percutaneous Coronary Intervention
N/ARecruiting
100 participants
Started: May 3, 2023 · Completed: Feb 28, 2025
2 conditions1 sponsor1 location
NCT05676593
Interest of FSL 2 in Recently Diagnosed Type 2 Diabetic Patients
NARecruiting
40 participants
Started: May 3, 2023 · Completed: Dec 3, 2024
2 conditions1 sponsor1 location